Andrew A. Radin is the co-founder and CEO of Aria Pharmaceuticals, a preclinical-stage pharmaceutical company focused on novel small molecule therapies for complex diseases. He developed the company's drug development algorithms during his biomedical informatics studies at Stanford University in 2014. Andrew's prior experience includes serving as CTO in successful internet startups, and he has been recognized as an Emerging Pharma Leader, given a TEDMED talk, and named a Top 100 AI Leader. He holds degrees in Biomedical Informatics, Computer Science, and has a background in telephony systems, advertising networks, video games, and geographical mapping systems.